Thursday November 26 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Panacea Pharmaceuticals

Panacea Pharmaceuticals, Inc. focuses on developing and utilizing protein-based technologies to detect and identify changes associated with and involved in diseases of the central nervous system such as Alzheimer's disease, brain tumors, transmissible spongiform encephalopathies, and Lewy Body diseases such as Parkinson's disease. Changes in disease-relevant proteins by altered expression, post-translational modification, and functional variation are utilized to develop diagnostic tests and therapeutic agents.


Contact Details:
9700 Great Seneca Highway
Rockville
MD
20850
United States of America
Tel:240 453 6295
Fax:240 465 0450
Email:info@PanaceaPharma.com
WWW:

www.panaceapharma.com/




Loading...

Recent Publications by Panacea Pharmaceuticals:

PAN-811 Inhibits Oxidative Stress-Induced Cell Death of Human Alzheimer's Disease-Derived and Age-Matched Olfactory Neuroepithelial Cells Via Suppression of Intracellular Reactive Oxygen Species.
Oxidative stress plays a significant role in neurotoxicity associated with...
13th May, 2009
Panacea Pharmaceuticals, Inc., Gaithersburg, MD, USA. J Alzheimers Dis. 2009 May 11.
DOI Direct Link
Potential application of RNAi for understanding and therapy of neurodegenerative diseases.
RNA interference (RNAi) technique has become a valuable tool in biology...
8th April, 2009
Panacea Pharmaceuticals, Inc., Gaithersburg, MD 20877, USA. Front Biosci. 2009 Jan 1;14:297-320.
Neuroprotective activity of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (PAN-811), a cancer therapeutic agent.
3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) is a...
9th September, 2006
Neurodegenerative Diseases, Panacea Pharmaceuticals, Inc., Gaithersburg, CNS Drug Rev. 2006 Spring;12(1):77-90.
DOI Direct Link
A multifunctional cytoprotective agent that reduces neurodegeneration after ischemia.
Cellular and molecular pathways underlying ischemic neurotoxicity are...
22nd March, 2006
Panacea Pharmaceuticals, Inc., Gaithersburg, MD 20877, USA. Proc Natl Acad Sci U S A. 2006 Jan 31;103(5):1581-6. Epub 2006 Jan 19.
DOI Direct Link
Risk Factors Versus Alzheimer's Disease or Symptoms Associated with Alzheimer's Disease.
Cellular and molecular pathways underlying ischemic neurotoxicity are...
6th September, 2002
Panacea Pharmaceuticals Inc., 9700 Great Seneca Highway, Rockville, MD J Alzheimers Dis. 2000 Jun;2(2):117.

View more Panacea Pharmaceuticals research publications.

Press Releases on Panacea Pharmaceuticals:

BioPortfolio Logo
New Report Just Published: World Prostate Cancer Therapeutics Market Report 7th July, 2009 Reportlinker
NEW YORK, July 7 /PRNewswire/ -- Reportlinker.com just added a new market research report to its catalogue. World Prostate Cancer Therapeutics Market http://www.reportlinker.com/p0119471/World
Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 3rd September, 2008 Panacea Pharmaceuticals, Inc.
GAITHERSBURG, Md., Sept. 3 /PRNewswire/ -- Panacea Pharmaceuticals, Inc. today announced the issuance of U.S. Patent Number 7,413,737 covering antibodies against human aspartyl (asparaginyl) beta
Panacea Pharmaceuticals Announces Appointment of Suzanne Sensabaugh as Vice President, Regulatory Affairs 5th August, 2008 Panacea Pharmaceuticals, Inc.
GAITHERSBURG, Md., Aug. 5 /PRNewswire/ -- Panacea Pharmaceuticals, Inc. today announced the appointment of Suzanne Sensabaugh as Vice President, Regulatory Affairs. Ms. Sensabaugh will assume

BioNews Results for Panacea Pharmaceuticals:

2 firms ready for clinical trials of swine flu vaccine
The Hindu:  Nov 22 2009 9:58PM Matching: panacea pharmaceuticals
2 firms ready for clinical trials of H1N1 vaccine
The Hindu:  Nov 22 2009 8:44PM Matching: panacea pharmaceuticals
Two pharma cos ready for trials of H1N1 vaccine
The Pioneer:  Nov 22 2009 6:40PM Matching: panacea pharmaceuticals
Two pharma cos ready for trials of H1N1 vaccine
Express India:  Nov 22 2009 12:19PM Matching: panacea pharmaceuticals
Two pharma cos ready for trials of H1N1 vaccine
Financial Express:  Nov 22 2009 9:49AM Matching: panacea pharmaceuticals
Promote your company here: BioNewsCast - Press Release Distribution

View more Panacea Pharmaceuticals news.

Panacea Pharmaceuticals Patents:

US Patent No.Title
7605133 Isolated peptides to treat alpha-synuclein diseases
7521479 Methods of treating prion disease in mammals
7456179 Methods of treating ischemic related conditions
6780971 Compositions for inhibiting the aggregation pathway of .alpha.-synuclein
6299875 Methods to block IGE binding to cell surface receptors of mast cells

View more Panacea Pharmaceuticals patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 1215 times since April 2007, the link to the organisation's website has been followed 206 times

Recent Search Terms used to find this page: panacea pharmaceuticals november 2009 | panacea pharmaceuticals november 2009 | PAN-811 panacea pharmaceuticals | J Panacea Pharmacueticals | panacea pharmaceuticals September 2009 | panacea pharmaceuticals august 2009 | Panacea Pharmaceuticals 2009 | panacea pharmaceuticals August 2009 | panacea pharmaceuticals 2009 | Panacea Pharmaceuticals Gaithersburg Md. | .

Search for more companies in Rockville

Search for more companies in MD



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Panacea Pharmaceuticals

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.